NCT06831500View on ClinicalTrials.gov

Feasibility Study Assessing the Effect of Carbidopa/levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Multi-system Atrophy - Parkinsonian TypeOrthostatic Hypotension, DysautonomicParkinson Disease

Interventions

DRUG

Administration of Carbidopa/levodopa

Participants will perform beat-by-beat orthostatic tests (Schellong tests) before and after intake of single doses of carbidopa:levodopa combinations at 3 different ratios

Trial Locations (1)

1012

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors

lead

Julien Bally

OTHER

NCT06831500 - Feasibility Study Assessing the Effect of Carbidopa/levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease. | Biotech Hunter | Biotech Hunter